Ordinary Index Rebalancing in the Solactive Obesity Index | January 2022

In the ordinary rebalance the following composition will be implemented effective open 01.02.2022:

ABIOMED INC
ADAPTHEALTH CORP
ANGIODYNAMICS INC
ARENA PHARMACEUTICALS INC
ARTIVION INC
BIONIME CORP
CARDIOVASCULAR SYSTEMS INC
CATO CORP-CLASS A
DARIOHEALTH CORP
DAVITA INC
DEXCOM INC
EKF DIAGNOSTICS HOLDINGS PLC
ESPERION THERAPEUTICS INC
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
FRESENIUS MEDICAL CARE AG & CO KGAA
HERBALIFE NUTRITION LTD
HUA MEDICINE
I-SENS INC
INSPIRE MEDICAL SYSTEMS INC
INSULET CORP
IRHYTHM TECHNOLOGIES INC
LEMAITRE VASCULAR INC
LEXICON PHARMACEUTICALS INC
LIFETECH SCIENTIFIC CORP
MADRIGAL PHARMACEUTICALS INC
MANNKIND CORP
MEDIFAST INC
MICROPORT SCIENTIFIC CORP
N BROWN GROUP PLC
NEMAURA MEDICAL INC
NGM BIOPHARMACEUTICALS INC
NIPRO (NISSHO) CORP ORD
NOVO NORDISK A/S
ORAMED PHARMACEUTICALS INC
POXEL SA
RESMED INC-CDI
RESVERLOGIX CORP
RHYTHM PHARMACEUTICALS INC
SENSEONICS HOLDINGS INC
TAIDOC TECHNOLOGY CORP
TANDEM DIABETES CARE INC
USANA HEALTH SCIENCES INC
WW INTERNATIONAL INC